Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial. (Q45050218)
Jump to navigation
Jump to search
scientific article published on 14 November 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial. |
scientific article published on 14 November 2014 |
Statements
Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial (English)
Glen A Kennedy
Antiopi Varelias
Slavica Vuckovic
Laetitia Le Texier
Ping Zhang
Lisa Anderson
Justine Leach
Elise Sturgeon
Judy Avery
Stuart D Olver
Mary Lor
Ashish K Misra
Cheryl Hutchins
A James Morton
Elango Subramoniapillai
Jason P Butler
Cameron I Curley